Published in Cancer Weekly, May 5th, 2009
"Molecularly, we revealed that RAR-beta(2) antitumor activity was associated with expression and suppression of cyclooxygenase-2 ( COX-2) in these tumor cell...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.